Abstract:We previously reported a potent tubulin inhibitor CH-2-77. In this study, we optimized the structure of CH-2-77 by blocking metabolically labile sites and synthesized a series of CH-2-77 analogues. Two compounds, 40a and 60c, preserved the potency while improving the metabolic stability over CH-2-77 by 3- to 4-fold (46.8 and 29.4 vs 10.8 min in human microsomes). We determined the high-resolution X-ray crystal structures of 40a (resolution 2.3 Å) and 60c (resolution 2.6 Å) in complex with tubulin and confirmed their direct binding at the colchicine-binding site. In vitro, 60c maintained its mode of action by inhibiting tubulin polymerization and was effective against P-glycoprotein-mediated multiple drug resistance and taxol resistance. In vivo, 60c exhibited a strong inhibitory effect on tumor growth and metastasis in a taxol-resistant A375/TxR xenograft model without obvious toxicity. Collectively, this work showed that 60c is a promising lead compound for further development as a potential anticancer agent.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00715.Electron densities of compounds colchicine (A), 40a (B), and 60c (C) within their respective tubulin–RB3-SLD (sT2R) complexes; expression of P-gp in parental and paclitaxel-resistant cell lines; 60c treatment induced tumor necrosis and antimetastasis in vivo; data collection and refinement statistics; and spectral data for the synthetic intermediates and all of the final compounds (PDF)Molecular formula strings and biological data (CSV)This article has not yet been cited by other publications.

The Design, Synthesis, in Vitro Biological Evaluation and Molecular Modeling of Novel Benzenesulfonate Derivatives Bearing Chalcone Moieties As Potent Anti- Microtubulin Polymerization Agents

Synthesis, Molecular Modeling and Biological Evaluation of Guanidine Derivatives As Novel Antitubulin Agents.

Design, Synthesis, and Biological Evaluation of Chalcone‐Containing Shikonin Derivatives As Inhibitors of Tubulin Polymerization

Combined Molecular Docking, 3D-QSAR, and Pharmacophore Model: Design of Novel Tubulin Polymerization Inhibitors by Binding to Colchicine-binding Site.

Design and Synthesis of (2-(Phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)meth Anone Analogues As Potent Anti-Tubulin Polymerization Agents

Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors

Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents

Design and evaluation of novel N-substituent diphenylamine derivatives as tubulin colchicine binding site inhibitors

Synthesis, Molecular Docking and Biological Evaluation of 1-Phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Novel Potential Tubulin Assembling Inhibitors

Synthesis, Molecular Modeling and Biological Evaluation of Dithiocarbamates As Novel Antitubulin Agents

Design, Synthesis and Biological Evaluation of Novel Chalcone Derivatives As Antitubulin Agents.

Design, Synthesis and Biological Evaluation of Novel Diarylpyridine Derivatives As Tubulin Polymerisation Inhibitors

Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Chalcone Oxime Derivatives As Potential Tubulin Polymerization Inhibitors

Synthesis, Biological Evaluation, and Molecular Modeling of Cinnamic Acyl Sulfonamide Derivatives As Novel Antitubulin Agents

Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities

Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site

Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site

Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors

Synthesis, Biological Evaluation, and Molecular Docking Studies of 2,6-Dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime Derivatives As Novel Antitubulin Agents.

Design, Synthesis and Biological Evaluation of 9-Aryl-5h-pyrido[4,3-b]indole Derivatives As Potential Tubulin Polymerization Inhibitors.